Evidence map›Paper›PMID 39745432›Full record

ReviewImmunological reviews2025

Biophysical and Structural Features of αβT-Cell Receptor Mechanosensing: A Paradigmatic Shift in Understanding T-Cell Activation.

Robert J Mallis, Kristine N Brazin, Jonathan S Duke-Cohan, Aoi Akitsu, Hanna M Stephens, Ana C Chang-Gonzalez, Daniel J Masi, Evan H Kirkpatrick, Elizabeth L Holliday, Yinnian Feng and 10 more

Abstract readReview
In one paragraph

Review in Immunological reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Mechanomedicine: Present state and future promise.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Atomistic TCR-ligand interactions instruct memory T-cell differentiation.bioRxiv : the preprint server for biology · 2025
    Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Robert J MallisLaboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Kristine N BrazinLaboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Jonathan S Duke-CohanLaboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Aoi AkitsuLaboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Hanna M StephensDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee, USA.
Ana C Chang-GonzalezDepartment of Biomedical Engineering, Texas A&M University, College Station, Texas, USA.
Daniel J MasiDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee, USA.
Evan H KirkpatrickDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee, USA.
Elizabeth L HollidayDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee, USA.
Yinnian FengDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee, USA.
Katarzyna J ZienkiewiczDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee, USA.
Jonathan J LeeLaboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Vincenzo CinellaLaboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Kaveri I UberoyLaboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Kemin TanStructural Biology Center, X-Ray Science Division, Advanced Photon Source, Argonne National Laboratory, Lemont, Illinois, USA.
Gerhard WagnerDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.
Haribabu ArthanariDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.
Wonmuk HwangDepartment of Biomedical Engineering, Texas A&M University, College Station, Texas, USA.
Matthew J LangDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee, USA.
Ellis L ReinherzLaboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.ORCID 0000-0003-1048-5526

Funding

Protein Production CoreP01AI143565 · NIAID · DANA-FARBER CANCER INST · PI Matthew J. Lang, ELLIS L REINHERZ · 2020 to 2026
$19.9M
Integrated Training in Engineering and DiabetesT32DK101003 · NIDDK · VANDERBILT UNIVERSITY · PI Jamey D. Young · 2014 to 2026
$3.9M
Understanding the structural basis of T cell receptor (TCR) and preTCR mechanosensing: single molecule, NMR and molecular dynamics studiesR01AI136301 · NIAID · VANDERBILT UNIVERSITY · PI LANG, MATTHEW J. · 2018 to 2022
$3.9M
National Institute of Allergy and Infectious Diseases 1P01AI143565National Institute of Allergy and Infectious Diseases RO1AI136301NIAID NIH HHS P01 AI143565NIAID NIH HHS R01 AI136301NIDDK NIH HHS T32 DK101003NIH HHS T32DK101003
6 · The paper itself

Abstract

αβT cells protect vertebrates against many diseases, optimizing surveillance using mechanical force to distinguish between pathophysiologic cellular alterations and normal self-constituents. The multi-subunit αβT-cell receptor (TCR) operates outside of thermal equilibrium, harvesting energy via physical forces generated by T-cell motility and actin-myosin machinery. When a peptide-bound major histocompatibility complex molecule (pMHC) on an antigen presenting cell is ligated, the αβTCR on the T cell leverages force to form a catch bond, prolonging bond lifetime, and enhancing antigen discrimination. Under load, the αβTCR undergoes reversible structural transitions involving partial unfolding of its clonotypic immunoglobulin-like (Ig) domains and coupled rearrangements of associated CD3 subunits and structural elements. We postulate that transitions provide critical energy to initiate the signaling cascade via induction of αβTCR quaternary structural rearrangements, associated membrane perturbations, exposure of CD3 ITAMs to phosphorylation by non-receptor tyrosine kinases, and phase separation of signaling molecules. Understanding force-mediated signaling by the αβTCR clarifies long-standing questions regarding αβTCR antigen recognition, specificity and affinity, providing a basis for continued investigation. Future directions include examining atomistic mechanisms of αβTCR signal initiation, performance quality, tissue compliance adaptability, and T-cell memory fate. The mechanotransduction paradigm will foster improved rational design of T-cell based vaccines, CAR-Ts, and adoptive therapies.

Indexed as

Lymphocyte ActivationMechanotransduction, CellularReceptors, Antigen, T-Cell, alpha-betaT-LymphocytesAnimalsHumansSignal TransductionReceptors, Antigen, T-Cell, alpha-betacell signalingmechanosensingmolecular dynamics (MD)optical tweezers (OT)preTCRsingle molecule (SM)T cellT‐cell receptor (TCR)

Identifiers

PMID39745432
PMCPMC11744257

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.